Alzheimer’s disease causes great suffering for patients and relatives and is among the costliest diseases for society. There is still no cure.
The researchers behind Cell Invent has a long and excellent track record in longitudinal dementia research and represent a unique combined expertise in preclinical and clinical Alzheimer’s disease.
Cell Invent offers a new way to find Alzheimer’s cures by developing new human disease models using reprogrammed Alzheimer patient cells.
Develops new human disease models based on reprogrammed Alzheimer patient cells.
Founded by Håkan Toresson, Lennart Minthon, Oskar Hansson and Camilla Orbjörn.
Portfolio company since 2019.
Portföljansvarig LU Holding:
christine [dot] widstrand [at] innovation [dot] lu [dot] se (Christine Widstrand), telefon +46 70 928 63 78